https://us.ono-pharma.com/daily1.0 https://us.ono-pharma.com/news/ono-enters-into-a-university-wide-research-alliance-agreement-with-harvard-university2024-03-11T17:57Zyearly https://us.ono-pharma.com/news/ono-pharma-announces-tirabrutinib-prospect-study-enrollment-is-complete2024-03-21T08:53Zyearly https://us.ono-pharma.com/about/leadership/heidi-friedman2024-04-11T21:42Zyearly https://us.ono-pharma.com/news/ono-pharma-usa-announces-2024-golden-ticket-competition-now-accepting-applications-from-innovative-startups2024-05-02T13:01Zyearly https://us.ono-pharma.com/news/ono-pharma-usa-announces-support-for-conquer-cancer-the-asco-foundation2024-06-25T13:21Zyearly https://us.ono-pharma.com/news/ono-pharmaceutical-co-ltd-announced-2024-q2-financial-results2024-10-31T21:52Zyearly https://us.ono-pharma.com/our-science/oncology2025-07-01T04:20Zyearly https://us.ono-pharma.com/news/ono-enters-into-drug-discovery-collaboration-agreement2024-12-05T23:28Zyearly https://us.ono-pharma.com/node/1462025-02-03T19:07Zyearly https://us.ono-pharma.com/our-science/immunology2025-07-01T04:20Zyearly https://us.ono-pharma.com/news/Ono-Announces-an-Oral-Presentation2025-04-24T00:00Zyearly https://us.ono-pharma.com/news/ONO_PHARMA_USA_Announces_2025Golden_Ticket_Competition2025-04-25T08:00Zyearly https://us.ono-pharma.com/our-science/neurology2025-07-01T04:20Zyearly https://us.ono-pharma.com/whatwedo2025-07-14T08:25Zyearly https://us.ono-pharma.com/node/1662025-07-29T05:00Zyearly https://us.ono-pharma.com/our-science/specialty2025-07-01T04:20Zyearly https://us.ono-pharma.com/node/1712025-07-25T07:27Zyearly https://us.ono-pharma.com/node/1762025-08-01T03:01Zyearly https://us.ono-pharma.com/node/1812025-10-10T01:18Zyearly https://us.ono-pharma.com/node/1862025-10-10T01:18Zyearly https://us.ono-pharma.com/node/192025-09-29T00:56Zyearly1.0 https://us.ono-pharma.com/node/1912025-10-30T04:00Zyearly https://us.ono-pharma.com/node/1962025-12-11T04:00Zmonthly https://us.ono-pharma.com/contact2023-10-11T18:26Znever https://us.ono-pharma.com/node/2012026-02-02T04:05Zalways https://us.ono-pharma.com/news/ono-pharma-usa-golden-ticket-competition2024-04-15T22:27Zyearly https://us.ono-pharma.com/news/tirabrutinib-receives-orphan-drug-designation2023-12-08T15:54Znever https://us.ono-pharma.com/about2023-10-16T15:59Znever https://us.ono-pharma.com/our-science2025-07-14T08:26Zyearly https://us.ono-pharma.com/news/ono-pharma-usa-continues-to-expand2024-04-15T22:26Zyearly https://us.ono-pharma.com/news/phase-1-study-ono-70182023-12-08T15:56Znever https://us.ono-pharma.com/news/initiation-phase-1-study-ono-46852024-05-03T18:03Zyearly https://us.ono-pharma.com/news/ono-pharma-usa-appoints-david-trexler-chief-commercial-officer2024-05-03T18:03Zyearly https://us.ono-pharma.com/news/phase-2-study-of-tirabruntinib2024-05-03T18:35Zyearly https://us.ono-pharma.com/news/ono-pharma-usa-launches-new-website2024-05-03T18:02Zyearly https://us.ono-pharma.com/news2023-10-11T18:26Znever https://us.ono-pharma.com/about/leadership/kunihiko-ito2024-05-20T21:08Zyearly https://us.ono-pharma.com/about/leadership/mitsunobu-tanimoto2023-12-08T15:51Znever https://us.ono-pharma.com/about/leadership/david-trexler2023-12-08T15:50Znever https://us.ono-pharma.com/about/leadership/howard-fingert2023-12-08T15:49Znever https://us.ono-pharma.com/about/leadership/u-shivraj-sohur2023-12-08T15:49Znever https://us.ono-pharma.com/about/leadership/thomas-lechner2023-12-08T15:49Znever https://us.ono-pharma.com/work-at-ono2025-07-01T04:12Zyearly https://us.ono-pharma.com/about/leadership/archana-sondhi2023-12-08T15:48Znever https://us.ono-pharma.com/about/leadership/sarala-gudiwada2023-12-08T15:47Znever https://us.ono-pharma.com/about/leadership/ralph-monaghan2023-12-08T15:47Znever https://us.ono-pharma.com/compliance2023-12-08T15:06Znever https://us.ono-pharma.com/news/ono-selected-for-the-djsi-world-index2023-12-19T18:15Znever https://us.ono-pharma.com/privacy-policy2023-11-01T18:33Znever https://us.ono-pharma.com/news/ono-enters-into-collaboration-agreement-with-EVQLV2023-12-21T22:07Znever https://us.ono-pharma.com/news/support-for-disasters-caused-by-the-2024-noto-peninsula-earthquake2024-01-10T15:05Znever https://us.ono-pharma.com/eap2025-07-10T06:29Zyearly https://us.ono-pharma.com/news/ONO-Selected-as-Highest-Rating-A-List-Company-by-CDP-in-Two-Categories-of-Climate-Change-and-Water-Security-in-CDP-20232024-02-13T20:30Zyearly https://us.ono-pharma.com/news/ono-enters-into-a-drug-discovery-collaboration2024-04-15T22:24Zyearly